Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales
UNSPECIFIED. (2006) Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. VACCINE, 24 (13). pp. 2377-2386. ISSN 0264-410XFull text not available from this repository.
Official URL: http://dx.doi.org/10.1016/j.vaccine.2005.11.055
A vaccination programme offering hepatitis B (HBV) vaccine at reception into prison has been introduced into selected prisons in England and Wales. The work here considers the impact of prison vaccination on the incidence and prevalence of hepatitis B virus (HBV) in the injecting drug user (IDU) population of England and Wales. A dynamic model of the transmission of HBV in IDUs is developed with key model assumptions and parameters being subject to sensitivity analyses.
The base case model (that assumes that the vaccination coverage on prison reception is 5% in 2002, 10% in 2003 and then increases linearly up to 50% of prison receptions being vaccinated by 2006) predicts that the incidence of HBV in IDUs might be reduced by almost 80% in 12 years, and the HBV prevalence (IDUs ever infected by HBV) may be reduced from approximately 18% in 2002 to 7% in 2015.
The model presented here demonstrates that HBV vaccination on prison reception can have a significant impact on the prevalence and incidence of HBV in the IDU population over time. (c) 2005 Elsevier Ltd. All rights reserved.
|Item Type:||Journal Article|
|Subjects:||Q Science > QR Microbiology > QR180 Immunology
|Journal or Publication Title:||VACCINE|
|Publisher:||ELSEVIER SCI LTD|
|Official Date:||20 March 2006|
|Number of Pages:||10|
|Page Range:||pp. 2377-2386|
Actions (login required)